Sigma-Aldrich's Q1 Sales Increase 10 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported 10 percent first-quarter revenue growth led by its SAFC business. On an organic basis, its revenues were up around 4 percent year over year.

The St. Louis-based chemicals and research tools firm brought in total revenues of $572 million for the three-month period ended March 31 compared to $519 million for the first quarter of 2009. The firm beat analysts' consensus estimate of $570.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.